| abstract |
Use of a protective agent(s) selected from the group of tumor necrosis factor -alpha and -beta, growth hormone, IL-1 and D-factor for the production of a composition suitable for protection, inhibition and prevention of the deleterious effects of reac-tive oxygen species, and administration of an effective amount of the protective agent(s). Treatment of tissues and organs to be transplanted are described. Perfusion solutions and the preparation of perfused, excised tissue are described. |